MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
IRD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Opus Genetics (IRD) Ownership - Who owns Opus Genetics?

Opus Genetics Inc is a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
337.28M
P/E Ratio
N/A
Total Cash
59.96M
Projected Growth
N/A
Total Debt
1.2M
Revenue
11.98M
Risk (Beta)
0.52
Dividend Yield
N/A
Total Cash/Share
0.73
Total Debt/Equity
N/A
Revenue/Share
0.16 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
IRD
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for IRD
A.I. Advisor
published General Information

General Information

a clinical stage biopharmaceutical company, which engages in the research and development of oncology therapeutics

Industry Biotechnology

Profile
Details